NAD World 3.0: Clarifying that chronic inflammation leads to the excessive consumption of NAD+, triggering the human aging process.
The NAD system, which regulates systemic aging, has expanded to include the central nervous system (hypothalamus), key tissues and organs (adipose tissue, skeletal muscle, gut), and cellular processes (protein synthesis and transport).
Today’s blog is centered around the newly updated model of NAD supplements which reflects on the recent advancements in the scientific circle’s understanding of how NAD really works. The author of today’s paper refer to this understanding as NAD World 3.0. Let’s first compare and contrast this updated understanding with the previously realized NAD World 1.0 and 2.0
Firstly, the NAD World framework, conceived by Dr. Shin-ichiro Imai, has fundamentally rewritten our understanding of mammalian aging. It evolved from a relatively simple, localized mechanism into a highly complex, multi-organ communication network.
The Evolution of the NAD World
NAD World 1.0 — The Foundation
2009
The Concept: Focused heavily on a localized, cellular feedback loop between a target and its energy source. It established a direct connection between SIRT1 (a longevity gene/protein) and NAMPT (the rate-limiting enzyme that makes NAD+).
Key Organs: The model primarily paired two tissues:
Adipose Tissue (Fat): Acted as the synthesizer, releasing systemic precursors.
Pancreatic Beta Cells: Acted as the primary recipient, relying on NAD+ to secrete insulin and regulate glucose metabolism.
NAD World 2.0 — The Brain-Body Connection
2016
The Concept: Shifted the theory from localized glucose control to a systemic, long-distance communication network. Version 2.0 proved that the body actively packages extracellular NAMPT (eNAMPT) into tiny bubbles called extracellular vesicles (EVs) to travel safely through the blood.
Key Organs: Expanded to a three-tissue loop:
The Hypothalamus: Solidified as the "Master Control Center" regulating systemic aging.
Adipose Tissue: Acted as the "Modulator," pumping out eNAMPT-EVs to fuel the hypothalamus.
Skeletal Muscle: Introduced as the "Mediator," responding to hypothalamic signals to maintain physical function.
NAD World 3.0 — The Dynamic Network
2025
The Concept: Solved the puzzle of how precursors enter the network and established a dual-speed system for processing them. It integrated how inflammaging (age-related chronic inflammation) active destroys NAD+ and introduced a specific doorway for rapid absorption.
Key Organs & Innovations: Added a fourth organ and a dual-lane delivery mechanism:
The Small Intestine: Added as the "Supply Manager," absorbing dietary precursors.
The Slc12a8 Transporter ("Fast Lane"): Discovered as a specific doorway that lets the small intestine and brain rapidly snap up NMN directly.
eNAMPT-EVs ("Slow Lane"): Fat-derived vesicles maintain long-term, background NAD+ synthesis over hours or days.
Core Structural Changes
A simple way to look at how the model expanded is tracking how the communication loop grew over time:
1.0 (2009): Localized Loop (Fat to Pancreas)
2.0 (2016): Systemic Triangle (Fat to Brain to Muscle)
3.0 (2025): Fully Integrated Quad-Network (Gut to Fat to Brain to Muscle, disrupted by Inflammaging)
By moving to version 3.0, the framework transitioned aging therapies away from just generic cellular support toward fixing highly specific network failures—like targeting the gut microbiome to improve precursor uptake or delivering eNAMPT-EVs straight to a sluggish hypothalamus.
Key Findings and Additional comments on NAD World 3.0
The "NAD World 3.0" by Dr. Shin-ichiro Imai updates his systemic framework for how mammalian aging and longevity are regulated. It shifts the view of aging from a localized, cell-by-cell breakdown to a systemic failure of communication between major organ systems, driven by a chronic drop in NAD+ (nicotinamide adenine dinucleotide).
1. The Core Driver: "Inflammaging" Directs NAD+ Decline
The article highlights that chronic, low-grade inflammation (often called "inflammaging") is the initial trigger that degrades the system. This inflammation activates specific immune cells (like macrophages and T-cells), which release cytokines that accelerate the systemic depletion of NAD+. This depletion causes two devastating results:
Mitochondrial failure: A dramatic drop in the cellular energy factory's redox balance.
Epigenetic shifts: Sweeping changes in how genes are expressed in the cell nucleus, locking in age-related decline.
2. The Four Control Centers (Organ Pillars)
NAD World 3.0 expanded its scope to show how four key tissues dynamically talk to one another through multi-layered feedback loops:
The Hypothalamus (The Control Center): Acts as the master brain region regulating aging. Different populations of neurons here manage communication with the rest of the body.
Adipose Tissue / Fat (The Modulator): Secretes eNAMPT (extracellular nicotinamide phosphoribosyltransferase), the crucial enzyme that travels through the blood to dictate how much NAD+ other organs can manufacture.
Skeletal Muscle (The Mediator): The body's major energy consumer. It relies on signals from the brain to keep up glycolysis (energy production) and protein synthesis.
Small Intestine (The Signal Generator): The newest addition to the framework. It acts as a primary entry point, absorbing dietary precursors to fuel the systemic network.
3. "Two Laneways" for NAD+ Repletion
A major breakthrough in the 3.0 model is defining exactly how these tissues transport and process energy precursors to fight aging, operating on a fast and slow dual-pathway system:
The "Fast Lane" via the Slc12a8 Transporter: The framework highlights Slc12a8, a highly specific, active transporter that allows cells to directly take up NMN (nicotinamide mononucleotide). In the small intestine, it snaps up dietary NMN for rapid conversion into NAD+. Furthermore, Slc12a8-positive neurons in the lateral hypothalamus (LH) use the sympathetic nervous system to tell skeletal muscles to synthesize protein and preserve mass.
The "Slow Lane" via eNAMPT-EVs: Fat tissue packages the critical enzyme eNAMPT into tiny bubbles called extracellular vesicles (EVs). These travel long distances through the bloodstream to systematically replenish long-term NAD+ biosynthesis in distant tissues, especially the hypothalamus.
Why This Matters
Instead of treating aging as a series of isolated structural breakdowns, NAD World 3.0 presents it as a network problem. When these multi-layered feedback loops fail—due to falling eNAMPT secretion or sluggish Slc12a8 transport—systemic aging accelerates. The paper concludes that targeted anti-aging therapies must focus on preserving this interconnected loop, specifically through gut microbiome interventions, eNAMPT-EV delivery, and targeted NMN supplementation.
Reference
Imai, S. NAD World 3.0: the importance of the NMN transporter and eNAMPT in mammalian aging and longevity control. npj Aging 11, 4 (2025).
